Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Mannion

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Biochimica Et Biophysica Acta|April 4, 2015
Structure-function relationships in histidine-rich antimicrobial peptides from Atlantic codMark McDonald, Michael Mannion, Damien Pike, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2010
Identification of a novel series of potent RON receptor tyrosine kinase inhibitorsStéphane Raeppel, Frédéric Gaudette, Michael Mannion, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
N3-arylmalonamides: a new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinasesOscar Saavedra, Stephen Claridge, Lijie Zhan, et al.
Infection Control and Hospital Epidemiology|April 5, 2011
Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measuresMamoon A Aldeyab, Michael J Devine, Peter Flanagan, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2009
N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsStéphane Raeppel, Stephen Claridge, Oscar Saavedra, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsMichael Mannion, Stéphane Raeppel, Stephen Claridge, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Biochimica Et Biophysica Acta|April 4, 2015
Structure-function relationships in histidine-rich antimicrobial peptides from Atlantic codMark McDonald, Michael Mannion, Damien Pike, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2010
Identification of a novel series of potent RON receptor tyrosine kinase inhibitorsStéphane Raeppel, Frédéric Gaudette, Michael Mannion, et al.
Bioorganic & Medicinal Chemistry Letters|November 10, 2009
N3-arylmalonamides: a new series of thieno[3,2-b]pyridine based inhibitors of c-Met and VEGFR2 tyrosine kinasesOscar Saavedra, Stephen Claridge, Lijie Zhan, et al.
Infection Control and Hospital Epidemiology|April 5, 2011
Multihospital outbreak of Clostridium difficile ribotype 027 infection: epidemiology and analysis of control measuresMamoon A Aldeyab, Michael J Devine, Peter Flanagan, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2009
N-(3-fluoro-4-(2-arylthieno[3,2-b]pyridin-7-yloxy)phenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsStéphane Raeppel, Stephen Claridge, Oscar Saavedra, et al.
Bioorganic & Medicinal Chemistry Letters|October 27, 2009
N-(4-(6,7-Disubstituted-quinolin-4-yloxy)-3-fluorophenyl)-2-oxo-3-phenylimidazolidine-1-carboxamides: a novel series of dual c-Met/VEGFR2 receptor tyrosine kinase inhibitorsMichael Mannion, Stéphane Raeppel, Stephen Claridge, et al.
Pageof 1